header_education

CRM Education

Reducing in-hospital ICD follow-up's safely - The TRUST Trial

User rating
 
0.0 (0)
Reducing in-hospital ICD follow-up's safely - The TRUST Trial

As the ICD population continues to grow at an exponential rate, the follow-up burden has also increased dramatically. In-hospital follow up visits are costly and time-consuming to the Physician, Cardiac Physiologist and patient. Currently, patients are usually seen at follow-up clinics every 3-6 months, depending on local protocols. The logistics of monitoring these devices have already placed a substantial and increasing burden on the follow up centre. In fact, it is estimated that in 2006 approximately 2,565,000 ICD follow-up1 visits were performed worldwide.

Read more...

The Burden II Trial - what have we learnt?

User rating
 
0.0 (0)
The Burden II Trial - what have we learnt?

In August 2003, Puglisi A et al first published the results of the Burden I trial in the European Heart Journal. This randomised study, presented some interesting findings with regards to atrial tachyarrhythmia burden in Brady-Tachy Syndrome. To accomplish this, the study compared overdrive pacing, the DDDR pacing mode and Closed Loop Stimulation (CLS).

Read more...

RV Pacing - How Low is Low Enough

User rating
 
0.0 (0)
RV Pacing - How Low is Low Enough

It is widely accepted that long term RV apical pacing has detrimental effects on the myocardial function and, as a result, the clinical outlook for patients. RV apical pacing facilitates an unnatural and unfamiliar depolarisation pathway giving an electrophysiological left bundle branch block appearance on the surface ECG. It is this unusual pathway that allows for remodelling of the LV. Le Clercq et al 1 reported this remodelling as thinning of the areas of myocardium which were activated earlier than normal and a characteristic thickening of the areas which were activated later than normal. The clinical picture of such patients is one of reduced systolic function, increased hospital admissions, worsening of CHF and increased incidence of AF. It is widely accepted that haemodynamically significant intrinsic activation is the gold standard where possible in patients requiring permanent pacing.

Read more...

Home Monitoring - is it really that effective?

User rating
 
0.0 (0)
Home Monitoring - is it really that effective?

With the launch of the first Home Monitoring system some seven years ago, there came a new and unique concept. Since that time, the technology has advanced at an exponential rate. Such systems are now capable of providing data on device and lead integrity, asymptomatic episodes, transmit IEGM’s and even real-time follow up information.

Read more...

Atrial Fibrillation & Cardiac Resynchronisation Therapy - can technology help?

User rating
 
0.0 (0)
Atrial Fibrillation & Cardiac Resynchronisation Therapy - can technology help?

Atrial Fibrillation (AF) and Congestive Heart Failure (CHF) are widespread cardiac disorders that are often concurrent. In fact, AF is found in 15 – 30% of patients with CHF, patients who experience these coexisting disorders also have a worse prognosis than CHF sufferers alone. Additionally, as patients New York Heart Association (NYHA) class increase, so does the prevalence of AF, from <10% in NHYA I to nearly 50% in NHYA IV sufferers. (1)

Read more...

More Articles...

Page 1 of 2

Start
Prev
1



3089_186x391_CardioBanner2